Charles River Laboratories | CRL - 贸易债权人

股票价格
156.03
每天变化
3.60 2.36%
每月一次
-14.78%
每年
15.59%
Q2 预测
147.82


金融业
股票价格
USD
资产
USD 7.73B
现金及等价物
USD 191.83M
销售成本
USD 716.51M
流动资产
USD 1.49B
流动负债
USD 1.09B
债务
USD 2.57B
EBIT
USD 119.9M
EBITDA
USD 229.8M
员工
18.6K
EPS每股收益
USD 2.06
股本和储备
USD 2.9B
销售毛利
USD 279.32M
债务利息支出
USD 26.74M
利息收入
USD -0.3
贷款资金
USD 2.66B
市值
USD 7.8B
净收入
USD -14.84M
营业费用
USD 875.93M
营业利润
USD 119.9M
普通股股本
USD 48.17M
PE价格收益
29.27
税前利润
USD -294.1M
销售收入
USD 995.8M
销售和管理费用
USD 159.42M
股票
USD 359.72M
贸易债权人
USD 133.95M
应收帐款人
USD 700.25M


贸易债权人 更改 日
Agilent USD 602M 32M 2025-12
Align Technology USD 123.72M 2.27M 2026-03
Bio-Rad Laboratories USD 133.1M 4.1M 2026-03
Bruker USD 269.1M 53.2M 2026-03
Cardinal Health USD 37.83B 1.16B 2026-03
Charles River Laboratories USD 133.95M 14.85M 2026-03
Cigna USD 9.88B 780M 2026-03
Concord Medical Services Hldg CNY 112.19M 19.4M 2025-06
CVS Health USD 58.59B 795M 2026-03
Danaher USD 1.79B 54M 2026-03
Dentsply International USD 259M 41M 2026-03
Elevance Health USD 6.21B 10.88B 2026-03
Humana USD 6.53B 814M 2026-03
Illumina USD 218M 22M 2026-03
Incyte USD 228.62M 1.41B 2026-03
Intrexon USD 4.85M 3.12M 2024-06
IQVIA Holdings USD 3.64B 112M 2026-03
Laboratory Of America USD 695.7M 145.1M 2026-03
Lakefront Biotherapeutics EUR 95.77M 8.88M 2026-03
Lonza CHF 471M 3M 2024-12
McKesson USD 59.97B 710M 2026-03
Merck EUR 2.13B 19M 2026-03
Mettler Toledo International USD 228.72M 37.91M 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
Quest Diagnostics USD 1.5B 100M 2026-03
Revvity USD 169.68M 15.78M 2026-03
Thermo Fisher Scientific USD 3.34B 278M 2026-03
United Therapeutics USD 498.3M 491.2M 2026-03
UnitedHealth USD 77.37B 37.19B 2025-12
Veradigm USD 30.84M 18.23M 2022-12
Waters USD 103.78M 11.95M 2025-12
West Pharmaceutical Services USD 252.3M 1.4M 2026-03